BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 32911906)

  • 1. [Comparison of the curative effect of transjugular intrahepatic portosystemic shunt with expanded polytetrafluoroethylene-covered stent and drug combined with gastroscopy as the secondary prevention of esophageal -gastric variceal bleeding in portal hypertension].
    Lin ZP; Chen SL; Wang JY; Liu F; Tan Q; Peng QF; Zhao JB
    Zhonghua Gan Zang Bing Za Zhi; 2020 Aug; 28(8):672-678. PubMed ID: 32911906
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcomes of Transjugular Intrahepatic Portosystemic Shunt and Gastric Coronary Vein Embolization for Variceal Bleeding in Cirrhotic Portal Hypertension.
    Mukhiya G; Han X; Jiao D; Bi Y; Pokhrel G; Liu Z; Li Z; He Y
    Clin Med Res; 2023 Sep; 21(3):144-154. PubMed ID: 37985166
    [No Abstract]   [Full Text] [Related]  

  • 3. Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis.
    Simonetti RG; Perricone G; Robbins HL; Battula NR; Weickert MO; Sutton R; Khan S
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD000553. PubMed ID: 33089892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transjugular intrahepatic collateral-systemic shunt is effective for cavernous transformation of the portal vein with variceal bleeding.
    Tie J; Gou X; He C; Li K; Yuan X; Jia W; Niu J; Han N; Xu J; Zhu Y; Wang W
    Hepatol Int; 2023 Aug; 17(4):979-988. PubMed ID: 37097537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis.
    Nardelli S; Riggio O; Marra F; Gioia S; Saltini D; Bellafante D; Adotti V; Guasconi T; Ridola L; Rosi M; Caporali C; Fanelli F; Roccarina D; Bianchini M; Indulti F; Spagnoli A; Merli M; Vizzutti F; Schepis F
    J Hepatol; 2024 Apr; 80(4):596-602. PubMed ID: 38097113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transjugular intrahepatic portosystemic shunt.
    Patidar KR; Sydnor M; Sanyal AJ
    Clin Liver Dis; 2014 Nov; 18(4):853-76. PubMed ID: 25438287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-mm shunt transjugular intrahepatic portosystemic shunt in patients with severe liver atrophy and variceal bleeding.
    Yan H; Xiang Z; Zhao C; Luo S; Liu H; Li M; Huang M
    Eur Radiol; 2023 Nov; ():. PubMed ID: 38006453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and prognosis of covered stents with different diameters in transjugular intrahepatic portosystemic shunt: a meta-analysis.
    Gong J; Xia Z; Zhou Z; Chen L; Wang X; Zhou F
    Eur J Gastroenterol Hepatol; 2024 Feb; 36(2):229-237. PubMed ID: 38131426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergency Transjugular Intrahepatic Portosystemic Shunt: an Effective and Safe Treatment for Uncontrolled Variceal Bleeding.
    Zhu Y; Wang X; Xi X; Li X; Luo X; Yang L
    J Gastrointest Surg; 2019 Nov; 23(11):2193-2200. PubMed ID: 30790218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TIPS prevents further decompensation and improves survival in patients with cirrhosis and portal hypertension in an individual patient data meta-analysis.
    Larrue H; D'Amico G; Olivas P; Lv Y; Bucsics T; Rudler M; Sauerbruch T; Hernandez-Gea V; Han G; Reiberger T; Thabut D; Vinel JP; Péron JM; García-Pagán JC; Bureau C
    J Hepatol; 2023 Sep; 79(3):692-703. PubMed ID: 37141993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised controlled trial of long term portographic follow up versus variceal band ligation following transjugular intrahepatic portosystemic stent shunt for preventing oesophageal variceal rebleeding.
    Tripathi D; Lui HF; Helmy A; Dabos K; Forrest E; Stanley AJ; Jalan R; Redhead DN; Hayes PC
    Gut; 2004 Mar; 53(3):431-7. PubMed ID: 14960530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of mortality and overt hepatic encephalopathy undergoing transjugular intrahepatic portosystemic shunt: a retrospective cohort study.
    Li K; Cheng Y; Zhao R; Jiang H; Zhang L; Tong Y; Li S
    Abdom Radiol (NY); 2024 Mar; 49(3):908-918. PubMed ID: 37957372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis of LSPD versus TIPS for the treatment of esophagogastric variceal bleeding in cirrhosis.
    Chen B; Wang J; Sheng W; Ma B; Xu P; Cheng X; Cheng W; Cai C; Wang G; Pan W; Wan C; Zheng C; Cheng P; Zhang J
    Surg Endosc; 2024 Apr; 38(4):2106-2115. PubMed ID: 38438672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Benefits of Underdilation of 8-mm Covered Stent in Transjugular Intrahepatic Portosystemic Shunt Creation.
    Liu J; Ma J; Zhou C; Yang C; Huang S; Shi Q; Xiong B
    Clin Transl Gastroenterol; 2021 Jun; 12(6):e00376. PubMed ID: 34140457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of long-term outcomes of splenectomy with periesophagogastric devascularization and transjugular intrahepatic portosystemic shunt in treating cirrhotic portal hypertension patients with recurrent variceal bleeding.
    Zhu W; Wang X; Lv Y; Chen H; Chen X; Li X; Zhu S; Lin Z; Wang G
    Langenbecks Arch Surg; 2023 May; 408(1):215. PubMed ID: 37247018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of early TIPS, Non-early TIPS, and Standard treatment in patients with cirrhosis and acute variceal bleeding: a network meta-analysis.
    Huang Y; Wang X; Li X; Sun S; Xie Y; Yin X
    Int J Surg; 2024 Feb; 110(2):1149-1158. PubMed ID: 37924494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial of emergency transjugular intrahepatic portosystemic shunt versus emergency portacaval shunt treatment of acute bleeding esophageal varices in cirrhosis.
    Orloff MJ; Vaida F; Haynes KS; Hye RJ; Isenberg JI; Jinich-Brook H
    J Gastrointest Surg; 2012 Nov; 16(11):2094-111. PubMed ID: 23007280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-emptive transjugular intrahepatic portosystemic shunt in pediatric cystic fibrosis-related liver disease and portal hypertension: prospective long-term results.
    Hermie L; Biervliet SV; Hoorens A; Cauwenberghe LV; Robberecht E; Defreyne L
    Diagn Interv Radiol; 2024 Jan; 30(1):55-64. PubMed ID: 36994654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individualized portal pressure gradient threshold based on liver function categories in preventing rebleeding after TIPS.
    Xia Y; Tie J; Wang G; Zhuge Y; Wu H; Xue H; Xu J; Zhang F; Zhao L; Huang G; Zhang M; Wei B; Li P; Wu W; Chen C; Tang C; Zhang C
    Hepatol Int; 2023 Aug; 17(4):967-978. PubMed ID: 36807252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Where does TIPS fit in the management of patients with cirrhosis?
    García-Pagán JC; Saffo S; Mandorfer M; Garcia-Tsao G
    JHEP Rep; 2020 Aug; 2(4):100122. PubMed ID: 32671331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.